Nicolas Galmarini
Nicolás is the CEO and co-founder of Nanogrow, a startup revolutionizing the pharmaceutical industry with innovative biological therapies based on camelid-derived nanobodies. With over 15 years of experience, he has worked across all stages of the pharmaceutical value chain, specializing in the development and management of pharma and biotech projects. He holds a degree in Economics, a Postgraduate in Investment Projects (Udelar, Uruguay), in Financial Consulting (Pompeu Fabra, Spain), and an MBA (Universidad Austral, Argentina). His approach focuses on execution, leadership, and innovation.
Nicolás believes in the transformative power of biotechnology and is committed to making this vision a reality through Nanogrow. He has evaluated innovative projects and is a speaker at international events, sharing his passion for biotech and his vision for the industry. He also advises several companies, driving growth and innovation, and is passionate about pushing the boundaries of science.
